Skip to content
Oriol Mirallas MD· @DrMirallas · X·· 2026-04-20Score60
Body

#AACR26

Dual Payload #ADC by
@AstraZeneca

MMAE DAR 2 + TOPI DAR 8 against #CD30
nnAA
Increased potency

New and more potent #ADC being developed and hopefully soon in the #phaseI trials

#oncology
@AACR

@OncoAlert

Heat 42 · 25 likes · 2 replies · 15 reposts

Source: Oriol Mirallas MD · x.com

CBACBA Frontier Insights (CFI)Chinese Biopharmaceutical Association (CBA)www.cba-usa.org